XML 77 R48.htm IDEA: XBRL DOCUMENT v3.25.4
The Group’s Business Reorganization and General Information (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 16, 2025
May 22, 2025
May 14, 2025
Jul. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Nov. 14, 2025
Jun. 30, 2022
The Group’s Business Reorganization and General Information [Line Items]                  
Shares received   1              
Shares held     10   80,370 60,083      
Par value (in Dollars per share)   $ 0.1           $ 1  
Number of shares reverse stock split   10              
Percentage of issued and outstanding equity interests 50.00% 50.00%              
Consideration for issued ordinary shares value 6,200,000                
Private warrant shares   500,000              
Private warrants exercise price (in Dollars per share) $ 20 $ 20              
Additional ordinary shares issue   12 months              
Shares outstanding, percentage 77.00%                
Voting interest percentage 98.00%                
Current debt (in Dollars)         $ 58,000,000        
Working capital (in Dollars)         (204,860,444)        
Shareholders' deficit (in Dollars)         (82,873,602) $ 250,001,370 $ 258,570,102   $ 124,869,117
Operating loss (in Dollars)         (104,150,129) 19,284,982 98,045,630    
Estimated gain (in Dollars)         9,500,000        
Moolec Science (Luxembourg) [Member[                  
The Group’s Business Reorganization and General Information [Line Items]                  
Consolidation ratio     ten-to-one            
Shares received     1            
Moolec Science (Cayman Islands) [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Par value (in Dollars per share)   $ 0.1              
Bioceres S.A [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Borrowings (in Dollars)         36,400,000        
Shareholders' deficit (in Dollars)         (91,042,130) 54,026,136      
Operating loss (in Dollars)         (91,566,943) $ (5,145,053) $ 3,194,004    
Approximate gain (in Dollars)         91,000,000        
Bioceres LLC [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Approximate gain (in Dollars)         $ 5,300,000        
Subsequent Events [Member] | Bioceres S.A [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Finance debt (in Dollars)       $ 69,500,000          
Shares pledged       3,062,500          
Bioceres Group Limited [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Shares received 500,000 450,000              
Consideration for issued ordinary shares value   6,200,000              
Bioceres Group Limited [Member] | Ordinary Shares [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Shares received   50,000              
Consideration for issued ordinary shares value   700,000              
Gentle Tech [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Shares received   132,750              
Gentle Tech [Member] | Ordinary Shares [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Shares received   14,750              
Holdback [Member]                  
The Group’s Business Reorganization and General Information [Line Items]                  
Percentage of equity and voting interest acquired   10.00%